MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

TearLab Corp Company Profile (NASDAQ:TEAR)

Consensus Ratings for TearLab Corp (NASDAQ:TEAR) (?)
Ratings Breakdown: 3 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 3.25)
Consensus Price Target: $3.56 (448.08% upside)

Analysts' Ratings History for TearLab Corp (NASDAQ:TEAR)
Show:
DateFirmActionRatingPrice TargetActions
5/5/2016Feltl & Co.UpgradeBuy -> Strong-BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2016Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2015Craig HallumLower Price TargetBuy$5.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for TearLab Corp (NASDAQ:TEAR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/4/2016Q1($0.23)($0.21)$6.53 million$6.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/8/2016Q4($0.25)($0.26)$6.83 million$6.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315($0.24)($0.24)$6.40 million$6.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.25)($0.24)$5.72 million$6.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115($0.21)($0.25)$5.40 million$5.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2015Q414($0.17)($0.21)$5.50 million$5.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2014Q214($0.17)($0.17)$5.50 million$5.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q114($0.16)($0.17)$5.12 million$9.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014Q1($0.14)($0.17)$4.76 million$4.21 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/13/2014Q413($0.13)($0.13)$4.49 million$4.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2013Q3($0.14)($0.13)$3.80 million$4.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/13/2013Q1 2013($0.12)($0.30)$2.18 million$2.47 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/13/2012Q312($0.11)($0.10)$1.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for TearLab Corp (NASDAQ:TEAR)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164($0.24)($0.22)($0.23)
Q2 20163($0.11)($0.06)($0.09)
Q3 20163($0.10)($0.05)($0.08)
Q4 20163($0.10)($0.04)($0.07)
(Data provided by Zacks Investment Research)
Dividend History for TearLab Corp (NASDAQ:TEAR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for TearLab Corp (NASDAQ:TEAR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/31/2016Brock WrightDirectorBuy59,686$0.78$46,555.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/26/2016Brock WrightDirectorBuy130,314$0.76$99,038.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2014Elias VamvakasCEOBuy50,000$2.24$112,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2014Elias VamvakasCEOBuy31,187$2.55$79,526.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2014Elias VamvakasCEOBuy18,813$2.55$47,973.15View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2014Elias VamvakasCEOBuy150,000$2.49$373,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2014Elias VamvakasCEOBuy16,276$2.50$40,690.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2014Joseph JensenCOOBuy43,375$2.31$100,196.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2014Brock WrightDirectorBuy23,000$3.82$87,860.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2014Brock WrightDirectorBuy11,354$3.83$43,485.82View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Elias VamvakasCEOBuy70,000$3.43$240,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/30/2014Richard LindstromDirectorSell5,000$4.61$23,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2014Elias VamvakasCEOBuy30,000$3.99$119,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2014Joseph JensenCOOBuy48,693$4.11$200,128.23View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2014Paul KarpeckiDirectorSell5,000$6.83$34,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2014Paul KarpeckiDirectorSell5,000$9.47$47,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/31/2013Richard LindstromDirectorSell5,000$9.26$46,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/15/2013Richard LindstromDirectorSell5,000$8.95$44,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/11/2013Paul KarpeckiDirectorSell5,000$10.96$54,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013William DumencuCFOSell7,000$13.22$92,540.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013William DumencuCFOSell7,000$14.39$100,730.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2013Paul KarpeckiDirectorSell5,000$10.62$53,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2013William DumencuCFOSell7,000$10.61$74,270.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013William DumencuCFOSell7,000$11.35$79,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/2/2013Tom Jr. DavidsonDirectorBuy1,500$6.63$9,945.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for TearLab Corp (NASDAQ:TEAR)
DateHeadline
06/23/16 07:29 PMTearLab : to Present at the 6th Annual LD Micro Invitational
06/17/16 09:24 AMContrast Sensitivity in Patients With Emmetropic Presbyopia Before and After Small-Aperture Inlay Implantation
06/04/16 09:51 AMTestosterone cream may provide relief from MGD-related dry eye
06/02/16 03:15 PMTearLab Corporation to Present at the 6th Annual LD Micro Invitational - [Accesswire] - SAN DIEGO, CA / ACCESSWIRE / June 2, 2016 / TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ("TearLab" or the "Company"), a company that develops and markets point of care ophthalmic in-vitro ...
05/25/16 12:42 PM5 Key Ophthalmology Takeaways: American Society of Cataract and Refractive Surgery (ASCRS) 2016 - Inflammation is known to be a long-standing culprit in OSD. Now we have point-of-care testing to evaluate both tear osmolarity (TearLab; San Diego, California) and markers of inflammation such as MMP-9 (RPS; Sarasota, Florida). Ocular surface inflammation ...
05/25/16 12:42 PMVIDEO: Surgeon recommends screening patients for ocular surface issues before cataract surgery - NEW ORLEANS — At the American Society of Cataract and Refractive Surgery meeting, Sumitra Khandelwal, MD, discusses how she uses TearLab's osmolarity test in her practice as a screening mechanism for cataract patients in order to optimize IOL lens ...
05/20/16 12:53 PMFeltl & Co. Upgrades TearLab Corp to Strong Buy - Trade Calls - Feltl & Co. Upgrades TearLab Corp to Strong BuyTrade CallsBrokerage firm Feltl & Co. Upgrades its rating on TearLab Corp(NASDAQ:TEAR). The shares have been rated Strong Buy. Previously, the analysts had a Buy rating on the shares. The rating by Feltl & Co. was issued on May 5, 2016. In a different note, On ...TearLab Corporation (TEAR) - Broker UpdateRisers & Fallersall 3 news articles »
05/17/16 12:04 PMTEARLAB CORP Financials -
05/12/16 03:54 PMETF’s with exposure to TearLab Corp. : May 12, 2016 -
05/12/16 07:14 AMForm 4 TearLab Corp For: May 09 Filed by: Jensen Joseph - StreetInsider.com - Form 4 TearLab Corp For: May 09 Filed by: Jensen JosephStreetInsider.comCheck this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). 1. Name and Address of Reporting Person *. Jensen Joseph. (Last), (First), (Middle). 9980 HUENNEKENS ST.,. STE 100. (Street). SAN DIEGO ...and more »
05/11/16 11:27 AMTearLab Corp. :TEAR-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/09/16 04:57 PMTEARLAB CORP Files SEC form 10-Q, Quarterly Report -
05/09/16 06:47 AMVIDEO: TearLab CEO gives business update - NEW ORLEANS — At the American Society of Cataract and Refractive Surgery meeting, Seph Jensen, CEO of TearLab, recaps his presentation at the Ophthalmology Innovation Summit, where he discussed a next-generation multiplex testing platform, and announces ...
05/08/16 06:30 AMBinkhorst Lecture: Epi-on cross-linking achieves favorable visual results for keratoconus, ectasia - Disclosure: Stulting reports he has financial interests with Abbott Medical Optics, Alcon, Allergan, Calhoun Vision, Cambium Technologies, Carl Zeiss Meditec, EyeYon, Ophtec, Optovue, TearLab and Vision Care Technologies.
05/06/16 06:56 AMAverage Analyst Rating for TearLab Corporation (NASDAQ:TEAR) - B.O.D.Y Confidential - Average Analyst Rating for TearLab Corporation (NASDAQ:TEAR)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 1 on TearLab Corporation (NASDAQ:TEAR) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks Research.and more »
05/06/16 06:56 AMForm RW TearLab Corp - StreetInsider.com - Form RW TearLab CorpStreetInsider.comPursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), TearLab Corporation (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) consent to the withdrawal, ...and more »
05/06/16 06:56 AMTop Analyst Actions: IAG, TEAR, WMGI, SCMP, FLOW - TearLab (NASDAQ: TEAR) Feltl & Co. raises to strong buy from buy Wright Medical Group (NASDAQ: WMGI) Wells Fargo raises to outperform from market perform Sucampo Pharma (NASDAQ: SCMP) WallachBeth raises to buy from hold SPX FLOW (NYSE: FLOW) Seaport Global ...
05/05/16 08:36 AMTearLab upgraded by Feltl & Co. -
05/05/16 06:49 AMTearLab's (TEAR) CEO Seph Jensen on Q1 2016 Results - Earnings Call Transcript - Seeking Alpha - TearLab's (TEAR) CEO Seph Jensen on Q1 2016 Results - Earnings Call TranscriptSeeking AlphaGood day, ladies and gentlemen and welcome to the TearLab Corporation Q1 2016 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that ...
05/05/16 06:49 AMBRIEF-Tearlab files for mixed shelf offering of up to $2.3 mln - SEC filing - Reuters - BRIEF-Tearlab files for mixed shelf offering of up to $2.3 mln - SEC filingReutersBRIEF-Tearlab files for mixed shelf offering of up to $2.3 mln - SEC filing. May 4 Tearlab Corp. * Files for mixed shelf offering of up to $2.3 million - SEC filing Source text for Eikon: [(1.usa.gov/1NVeqxn )] Further company coverage: (Bengaluru ...
05/05/16 06:49 AMBRIEF-Tearlab Corporation Q1 loss per share $0.21 - Reuters - BRIEF-Tearlab Corporation Q1 loss per share $0.21ReutersMay 4 (Reuters) -. * Tearlab Corporation Reports Q1 16 financial results. * Q1 loss per share $0.21. * Q1 revenue $6.8 million versus I/B/E/S view $6.5 million. * Sees FY 2016 revenue up 15 to 20 percent. * Q1 earnings per share view $-0.23 -- Thomson ...
05/05/16 06:49 AMBRIEF-TearLab announces $17.3 mln registered public offering - Reuters - BRIEF-TearLab announces $17.3 mln registered public offeringReutersMay 4 TearLab Corp : * Tearlab announces $17.3 million registered public offering. * Tearlab corp says offering was priced at $0.75 per share of common stock Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780) ...
05/05/16 06:49 AMTearLab's (TEAR) CEO Seph Jensen on Q1 2016 Results - Earnings Call Transcript - Good day, ladies and gentlemen and welcome to the TearLab Corporation Q1 2016 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time.
05/04/16 04:51 PMTearLab reports 1Q loss -
05/04/16 03:41 PMTearLab Corporation Reports Q1-16 Financial Results - [at noodls] - SAN DIEGO, May 04, 2016 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ('TearLab' or the 'Company') today reported its consolidated financial results for the first quarter ended March ...
05/04/16 03:02 PMTEARLAB CORP Files SEC form 8-K, Results of Operations and Financial Condition -
05/04/16 06:20 AMTearLab Announces $17.3 Million Registered Public Offering - [at noodls] - SAN DIEGO, May 04, 2016 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ('TearLab' or the 'Company') announced today the pricing of a public offering of the Company's common stock, resulting ...
05/04/16 06:07 AMQ1 2016 TearLab Corp Earnings Release - After Market Close -
05/04/16 06:01 AM7:01 am TearLab announces a registered public offering priced at $0.75/share for gross proceeds of $17.3 mln -
05/04/16 05:51 AMTearLab Corporation (NASDAQ:TEAR) Boasts An Average Rating Of 5 - Stocks Daily - TearLab Corporation (NASDAQ:TEAR) Boasts An Average Rating Of 5Stocks DailyAlpha One applies algorithm-based analytics for assessing a stock sentiment as per the published released on web channels. In this evaluation process, the group accesses the most relevant news platforms on a daily basis. TearLab Corporation ...and more »
05/04/16 05:51 AMBRIEF-Tearlab files for mixed shelf offering of up to $2.3 mln - SEC filing - * Files for mixed shelf offering of up to $2.3 million - SEC filing Source text for Eikon: [(1.usa.gov/1NVeqxn)] Further company coverage: (Bengaluru Newsroom: +1 646 223 8780) Thomson Reuters is the world's largest international multimedia news agency ...
05/03/16 06:32 AMDisruptive technology – Sometimes beneficial, sometimes ‘scary’ - He is on the speakers’ bureau for Glaukos and Oculus; has conducted research for Akorn, Allergan, Bausch + Lomb, Eleven Biotherapeutics, Fera Pharmaceuticals, Rigel Pharma and Shire; and has an ownership interest in Bruder HealthCare and TearLab.
04/29/16 07:21 AMShare Performance and Target Price Review TearLab Corporation (NASDAQ:TEAR) - B.O.D.Y Confidential - Share Performance and Target Price Review TearLab Corporation (NASDAQ:TEAR)B.O.D.Y ConfidentialDuring the most recent trading session, shares of TearLab Corporation (NASDAQ:TEAR) ended up with a move of +6.65%. Sell-side analysts have given a consensus target price of $2.63 on company shares. Target price projections may differ greatly from ...and more »
04/29/16 07:21 AMTearLab Corporation (NASDAQ:TEAR) Share Rating Recap - B.O.D.Y Confidential - TearLab Corporation (NASDAQ:TEAR) Share Rating RecapB.O.D.Y ConfidentialShares of TearLab Corporation (NASDAQ:TEAR) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from ...TearLab Corporation (NASDAQ:TEAR) Analyst Rating ReviewThe Postall 251 news articles »
04/28/16 06:54 AMTearLab Corporation (NASDAQ:TEAR) Analyst Rating Review - The Post - TearLab Corporation (NASDAQ:TEAR) Analyst Rating ReviewThe PostCurrently, there are 3 analysts that have provided ratings for TearLab Corporation (NASDAQ:TEAR). 3 have rated the stock a “Strong Buy”, 0 rate it a “Buy”, 0 are putting a Hold rating on the stock, and 0 are recommending “Sell”. Every recommendation ...and more »
04/27/16 07:56 AMTearLab Corporation (NASDAQ:TEAR) Share Rating Recap - The Post - TearLab Corporation (NASDAQ:TEAR) Share Rating RecapThe PostShares of TearLab Corporation (NASDAQ:TEAR) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from ...and more »
04/27/16 07:56 AMWere Analysts Bullish TearLab Corp (NASDAQ:TEAR) This Week? - CCH Daily News - Were Analysts Bullish TearLab Corp (NASDAQ:TEAR) This Week?CCH Daily NewsOut of 4 analysts covering Tearlab Corporation (NASDAQ:TEAR), 4 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Tearlab Corporation has been the topic of 3 analyst reports since August 7, 2015 according to StockzIntelligence Inc.TearLab Corporation (NASDAQ:TEAR): Quarterly EPS Estimate Of $-0.15Investor NewswireTearLab Corporation (NASDAQ:TEAR) Wall Street Rating in FocusNews Tribuneall 3 news articles »
04/26/16 07:31 AMExpert panel shares pearls on punctal occlusion - April 14-17; New York. Disclosures: Bloomenstein is on the speakers’ panel for Abbott Medical Optics, Alcon, Allergan, Bausch + Lomb, Better Vision Institute, BlephEx, Bruder, Macular Health and TearLab. Karpecki receives consulting fees from AcuFocus ...
04/25/16 08:00 AMTearLab to Release First Quarter 2016 Financial Results on May 4, 2016 – Conference Call to Follow - [at noodls] - SAN DIEGO, April 25, 2016 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ('TearLab' or the 'Company') will announce its first quarter 2016 financial results after market close on Wednesday, ...
04/24/16 06:49 AMTearlab Corporation (NASDAQ:TEAR) Sellers Covered 6.86% of Their Shorts - CCH Daily News - Tearlab Corporation (NASDAQ:TEAR) Sellers Covered 6.86% of Their ShortsCCH Daily NewsThe stock of Tearlab Corporation (NASDAQ:TEAR) registered a decrease of 6.86% in short interest. TEAR's total short interest was 2.32M shares in April as published by FINRA. Its down 6.86% from 2.49 million shares, reported previously. With 157,000 ...
04/23/16 06:59 AMProactive approach to OSD improves surgical outcomes, contact lens success - We address this in our practice.” Bloomenstein also noted that a study conducted by TearLab showed that an eye with higher osmolarity changes the A-scan measurements. “You can be off by a full diopter if the ocular surface is not optimized,” Karpecki ...
04/22/16 07:42 AMTearLab Corporation (TEAR) Updated Broker Price Targets - Share Trading News - TearLab Corporation (TEAR) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of TearLab Corporation (TEAR). The latest reports which are currently in issue on Thursday 21st of April state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...and more »
04/21/16 07:35 AMTearLab (TEAR) Prelim. Q1 Revenue Tops Views - StreetInsider.com - TearLab (TEAR) Prelim. Q1 Revenue Tops ViewsStreetInsider.comTearLab Corporation (NASDAQ: TEAR) announced certain preliminarily unaudited financial estimates for the first quarter of 2016. TearLab estimates that total revenue for the quarter ended March 31, 2016 will be approximately $6.8 million, reflecting an ...and more »
04/21/16 07:35 AMBRIEF-TearLab says estimates Q1 total revenue will be about $6.8 mln - Reuters - BRIEF-TearLab says estimates Q1 total revenue will be about $6.8 mlnReutersApril 20 TearLab Corp. * TearLab announces first quarter 2016 preliminary financial estimates. * TearLab Corp says estimates that total revenue for quarter ended March 31, 2016 will be approximately $6.8 million Source text for Eikon: Further company ...
04/21/16 07:35 AMBRIEF-TearLab says estimates Q1 total revenue will be about $6.8 mln - * TearLab Corp says estimates that total revenue for quarter ended March 31, 2016 will be approximately $6.8 million Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
04/21/16 05:09 AMTEARLAB CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -
04/20/16 04:52 PMTearLab Announces First Quarter 2016 Preliminary Financial Estimates - [at noodls] - SAN DIEGO, April 20, 2016 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) ('TearLab' or 'the Company') announced today certain preliminarily unaudited financial estimates for the first ...
04/19/16 07:57 AM3 steps to improve ocular health of dry eye patients - ModernMedicine - 3 steps to improve ocular health of dry eye patientsModernMedicineThough osmolarity has been difficult to determine in the past, the advent of devices (such as the TearLab Osmolarity System, TearLab Corp.) have made the process easier. Determining osmolarity is vital, as it will be higher in a number of dry eye ...
04/19/16 07:57 AM3 steps to improve ocular health of dry eye patients - Though osmolarity has been difficult to determine in the past, the advent of devices (such as the TearLab Osmolarity System, TearLab Corp.) have made the process easier. Determining osmolarity is vital, as it will be higher in a number of dry eye etiologies.
04/17/16 06:29 AMTearLab Corporation (NASDAQ:TEAR): Quarterly EPS Estimate Of $-0.15 - RealistInvestor.com - TearLab Corporation (NASDAQ:TEAR): Quarterly EPS Estimate Of $-0.15RealistInvestor.comThe EPS estimates reported seven and 30 days ago were $-0.15 and $-0.15 respectively. While the EPS estimates reported 60 and 90 days ago were $-0.15 and $-0.15 respectively. The percentage change in EPS_MEAN_EST from 7 days ago is 0%.and more »
About TearLab Corp

TearLab Corp logoTearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TEAR
  • CUSIP:
Key Metrics:
  • Previous Close: $0.65
  • 50 Day Moving Average: $0.74
  • 200 Day Moving Average: $0.92
  • P/E Ratio: N/A
  • P/E Growth: -0.06
  • Market Cap: $22.24M
  • Current Quarter EPS Consensus Estimate: $-0.40 EPS
Additional Links:
TearLab Corp (NASDAQ:TEAR) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha